Home Prognostic value of heart rate variability in acute coronary syndrome
Article
Licensed
Unlicensed Requires Authentication

Prognostic value of heart rate variability in acute coronary syndrome

  • Smitha Pernaje Seetharam ORCID logo , Vinutha Shankar MS ORCID logo EMAIL logo , Kaviraja Udupa ORCID logo , Raveesha A. and Niranjan Reddy
Published/Copyright: October 4, 2022

Abstract

Objectives

To assess the predictive value of pre-discharge heart rate variability (HRV) parameters in patients with acute coronary syndrome (ACS) treated by percutaneous coronary intervention (PCI).

Methods

145 consecutive male patients with ACS (aged 57.12 ± 10.81 years) were included in this study. Fifteen minutes electrocardiogram recording was done to measure time-domain [standard deviation of N–N intervals (SDNN), root-mean square differences of successive R–R intervals (rMSSD)] and frequency-domain [low-frequency (LF) power, high-frequency (HF) power and total power (TP)] HRV parameters before and after PCI. The primary end point was the occurrence of major clinical events (MCE) defined as death, sudden death or re-acute myocardial infarction at the end of 3 months follow-up.

Results

At a follow-up of 3 months, MCE occurred in 06 patients (4.14%) (Cardiac death was 3.01%, while that of sudden death was 1.13%). Out of six-MCE, four deaths and two re-AMIs occurred. Pre-discharge HRV values (SDNN, rMSSD, TP, LF and HF) were significantly lower in patients with ACS without MCE. Only total power HRV index (AUC=0.748; p=0.040) showed greater prognostic accuracy.

Conclusions

In conclusion, study showed an increase in SDNN, rMSSD, LF, HF and TP after successful revascularization with PCI in patients who had MCE. The resultant sensitivity, specificity of HRV is still limited in the present study. Particularly, its sensitivity is higher (33–83%) with a modest specificity (61–72%).


Corresponding author: Vinutha Shankar MS, MD, Prof and Head, Department of Physiology, Sri Devaraj Urs Medical College, Sri Devaraj Urs Academy of Higher Education and Research, Tamaka, Kolar 563103, Karnataka, India, Phone: +919845065374, 08152 243003, Fax: +91 (8152) 243008, E-mail:

Acknowledgments

The authors would immensely thank the statistical help given by Mr. Ravishankar, Biostatistician, Department of Community Medicine, Sri Devaraj Urs Medical College, Kolar.

  1. Research funding: None declared.

  2. Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  3. Competing interests: Authors state no conflict of interest.

  4. Informed consent: Informed consent was obtained from all individuals included in this study.

  5. Ethical approval: The study was approved by the Central Ethics Committee (CEC No. SDUAHER/KLR/R & I/91/2021-22 dated 9-3-2021).

References

1. Amsterdam, EA, Wenger, NK, Brindis, RG, Casey, DE, Ganiats, TG, Holmes, DR, et al.. AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American heart association task force on practice guidelines. J Am Coll Cardiol 2014;64:e139–228. https://doi.org/10.1016/j.jacc.2014.09.017.Search in Google Scholar PubMed

2. Hyun, KK, Essue, BM, Woodward, M, Jan, S, Brieger, D, Chew, D, et al.. The household economic burden for acute coronary syndrome survivors in Australia. BMC Health Serv Res 2016;16:636. https://doi.org/10.1186/s12913-016-1887-3.Search in Google Scholar PubMed PubMed Central

3. Torres, M, Moayedi, S. Evaluation of the acutely dyspneic elderly patient. Clin Geriatr Med 2007;23:307–25. https://doi.org/10.1016/j.cger.2007.01.007.Search in Google Scholar PubMed

4. Brateanu, A. Heart rate variability after myocardial infarction. What we know and what we still need to find out. Curr Med Res Opin 2015;31:1855–60. https://doi.org/10.1185/03007995.2015.1086992.Search in Google Scholar PubMed

5. Coviello, I, Pinnacchio, G, Laurito, M, Stazi, A, Battipaglia, I, Barone, L, et al.. Prognostic role of heart rate variability in patients with ST-segment elevation acute myocardial infarction treated by primary angioplasty. Cardiology 2013;124:63–70. https://doi.org/10.1159/000345779.Search in Google Scholar PubMed

6. Abrootan, S, Yazdankhah, S, Payami, B, Alasti, M. Changes in heart rate variability parameters after elective percutaneous coronary intervention. J Tehran Heart Cent 2015;10:80–4.Search in Google Scholar

7. Gulati, M, Levy, PD, Mukherjee, D, Amsterdam, E, Bhatt, DL, Birtcher, KK, et al.. 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR guideline for the evaluation and diagnosis of chest pain: a report of the American College of Cardiology/American heart association joint committee on clinical practice Guidelines. Circulation 2021;144:e368–454, Erratum in: Circulation 2021;144:e455. https://doi.org/10.1161/CIR.0000000000001029.Search in Google Scholar PubMed

8. Collet, JP, Thiele, H, Barbato, E, Barthe´le´my, O, Bauersachs, J, Bhatt, DL, et al.. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. The Task Force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 2021;42:12891367. https://doi.org/10.1093/eurheartj/ehaa575.Search in Google Scholar PubMed

9. U.S. Department of Health and Human Services. The health consequences of Smoking-50 years of progress: a report of the surgeon general. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2014. Available from: https://www.ncbi.nlm.nih.gov/books/NBK179276/ [Accessed 22 Mar 2018].Search in Google Scholar

10. Hackshaw, A, Morris, JK, Boniface, S, Tang, JL, Milenković, D. Low cigarette consumption and risk of coronary heart disease and stroke: meta-analysis of 141 cohort studies in 55 study reports. BMJ 2018;363:k5035. https://doi.org/10.1136%2Fbmj.j5855.10.1136/bmj.j5855Search in Google Scholar PubMed PubMed Central

11. Tomiyama, H, Nakayama, T, Watanabe, G, Shiojim, K, Sakuma, Y, Yamamoto, A. Effects of short-acting and long-acting loop diuretics on heart rate variability in patients with chronic compensated congestive heart failure. Am Heart J 1999;137:543–8. https://doi.org/10.1016/S0002-8703(99)70504-1.Search in Google Scholar

12. Pivatelli, FC, Santos, MA, Fernandes, GB, Gatti, M, Abreu, LC, Valenti, VE, et al.. Sensitivity, specificity and predictive values of linear and nonlinear indices of heart rate variability in stable angina patients. Int Arch Med 2012;5:31. https://doi.org/10.1186/1755-7682-5-31.Search in Google Scholar PubMed PubMed Central

13. Harris, PR, Stein, PK, Fung, GL, Drew, BJ. Heart rate variability measured early in patients with evolving acute coronary syndrome and 1-year outcomes of rehospitalization and mortality. Vasc Health Risk Manag 2014;10:451–64. https://doi.org/10.2147/VHRM.S57524.Search in Google Scholar PubMed PubMed Central

14. Exner, DV, Kavanagh, KM, Slawnych, MP, Mitchell, LB, Ramadan, D, Aggarwal, SG, et al.. Noninvasive risk assessment early after a myocardial infarction: the REFINE study. J Am Coll Cardiol 2007;50:2275–84.10.1016/j.jacc.2007.08.042Search in Google Scholar PubMed

15. Balanescu, S, Corlan, AD, Dorobantu, M, Gherasim, L. Prognostic value of heart rate variability after acute myocardial infarction. Med Sci Monit 2004;10:307–15.Search in Google Scholar

16. Erdogan, A, Coch, M, Bilgin, M, Parahuleva, M, Tillmanns, H, Waldecker, B, et al.. Prognostic value of heart rate variability after acute myocardial infarction in the era of immediate reperfusion. Herzschr Elektrophys 2008;19:161–8. https://doi.org/10.1007/s00399-008-0024-3.Search in Google Scholar PubMed

17. Airaksinen, KE, Ikäheimo, MJ, Linnaluoto, MK, Niemelä, M, Takkunen, JT. Impaired vagal heart rate control in coronary artery disease. Br Heart J 1987;58:592–7. https://doi.org/10.1136/hrt.58.6.592.Search in Google Scholar PubMed PubMed Central

18. Lindenfeld, J, Schrier, RW. Blood urea nitrogen a marker for adverse effects of loop diuretics? J Am Coll Cardiol 2011;58:383–5. https://doi.org/10.1016/j.jacc.2011.01.054.Search in Google Scholar PubMed

19. Jujo, K, Minami, Y, Haruki, S, Matsue, Y, Shimazaki, K, Kadowaki, H, et al.. Persistent high blood urea nitrogen level is associated with increased risk of cardiovascular events in patients with acute heart failure. ESC Heart Fail 2017;4:545–53. https://doi.org/10.1002/ehf2.12188.Search in Google Scholar PubMed PubMed Central

20. Hsin, HT, Yang, CY, Yeih, DF, Shieh, JS, Li, AH. The detrended fluctuation analysis of acute-phase heart-rate variability in acute coronary syndromes – a pilot study. Int J Cardiol 2010;140:252–5. https://doi.org/10.1016/j.ijcard.2008.11.044.Search in Google Scholar PubMed

21. Saito, K, Saito, Y, Kitahara, H, Nakayama, T, Fujimoto, Y, Kobayashi, Y. In-hospital blood pressure variability: a novel prognostic marker of renal function decline and cardiovascular events in patients with coronary artery disease. Kidney Blood Press Res 2020;45:748–57. https://doi.org/10.1159/000509291.Search in Google Scholar PubMed

22. Mäkikallio, TH, Huikuri, HV, Hintze, U, Videbaek, J, Mitrani, RD, Castellanos, A, et al.. Fractal analysis and time and frequency-domain measures of heart rate variability as predictors of mortality in patients with heart failure. Am J Cardiol 2001;87:178–82. https://doi.org/10.1016/s0002-9149(00)01312-6.Search in Google Scholar PubMed

23. Huikuri, HV, Mäkikallio, TH, Peng, CK, Goldberger, AL, Hintze, U, Moller, M. Fractal correlation properties of R–R interval dynamics and mortality in patients with depressed left ventricular function after an acute myocardial infarction. Circulation 2000;101:47–53. https://doi.org/10.1161/01.cir.101.1.47.Search in Google Scholar PubMed

24. Tapanainen, JM, Thomsen, PEB, Køber, L, Torp-Pedersen, C, Mäkikallio, TH, Still, AM, et al.. Fractal analysis of heart rate variability and mortality after an acute myocardial infarction. Am J Cardiol 2002;90:347–52. https://doi.org/10.1016/s0002-9149(02)02488-8.Search in Google Scholar PubMed

Received: 2022-05-12
Accepted: 2022-09-05
Published Online: 2022-10-04

© 2022 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Editorial
  3. Investigating periprostatic adipose tissue as a driving force of prostate cancer progression: a new source of information for the advancement of targeted therapy in metastatic prostate cancer
  4. Reviews
  5. Pathophysiological effects of cadmium(II) on human health-a critical review
  6. The role of synbiotics in improving inflammatory status in nasopharyngeal carcinoma patients
  7. Anti-ageing effects of FDA-approved medicines: a focused review
  8. Diagnosis and management of uterine fibroids: current trends and future strategies
  9. Importance of moderate-to-vigorous physical activity during the COVID-19 pandemic: a systematic review and meta-analysis
  10. Original Articles
  11. Healthcare workers’ knowledge of evidence-based guidelines for prevention of ventilator-associated pneumonia in Hodeida, Yemen
  12. Comparison of cardiac autonomic function across complete glycaemic spectrum
  13. Prognostic value of heart rate variability in acute coronary syndrome
  14. Insights into the protective capacity of human dental pulp stem cells and its secretome in cisplatin-induced nephrotoxicity: effects on oxidative stress and histological changes
  15. Caffeine impairs anticonvulsant effects of levetiracetam in the maximal electroshock seizure threshold test in mice
  16. Antioxidant activity in off and on-pump coronary artery bypass grafting and valve replacement surgery
  17. A drug utilisation pattern in non-dialysis patients of diabetic nephropathy in a government-run tertiary care hospital in South-Asia
  18. Inguinal lymphadenectomy in penile cancer patients: a comparison between open and video endoscopic approach in a multicenter setting
  19. A randomized controlled trial to evaluate the efficacy of electrical vestibular nerve stimulation (VeNS), compared to a sham control for the management of sleep in young adults
  20. Short Communication
  21. The role of Bruton’s kinase inhibitors (BTKi) in accelerated Chronic Lymphocytic Leukemia (a-CLL): a case of successful response to acalabrutinib
  22. Letter to the Editor
  23. A hypothesis that Notopterol may be effective in COVID-19 via JAK/STAT and other signaling pathways
Downloaded on 28.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jbcpp-2022-0134/html
Scroll to top button